173 related articles for article (PubMed ID: 36212776)
21. Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors.
Ishi Y; Zhang Y; Zhang A; Sasaki T; Piunti A; Suri A; Watanabe J; Abe K; He X; Katagi H; Bhalla P; Natsumeda M; Zou L; Shilatifard A; Hashizume R
Mol Cancer Ther; 2022 May; 21(5):715-726. PubMed ID: 35247919
[TBL] [Abstract][Full Text] [Related]
22. [EZH inhibitors in lymphoma therapy].
Ishitsuka K
Rinsho Ketsueki; 2023; 64(7):665-669. PubMed ID: 37544728
[TBL] [Abstract][Full Text] [Related]
23. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair.
Ezhkova E; Lien WH; Stokes N; Pasolli HA; Silva JM; Fuchs E
Genes Dev; 2011 Mar; 25(5):485-98. PubMed ID: 21317239
[TBL] [Abstract][Full Text] [Related]
24. Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2.
Lau-Corona D; Bae WK; Hennighausen L; Waxman DJ
PLoS Genet; 2020 May; 16(5):e1008796. PubMed ID: 32428001
[TBL] [Abstract][Full Text] [Related]
25. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
[TBL] [Abstract][Full Text] [Related]
26. Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas.
Schümann FL; Groß E; Bauer M; Rohde C; Sandmann S; Terziev D; Müller LP; Posern G; Wienke A; Fend F; Hansmann ML; Klapper W; Rosenwald A; Stein H; Dugas M; Müller-Tidow C; Wickenhauser C; Binder M; Weber T
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944658
[TBL] [Abstract][Full Text] [Related]
27. Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome.
Aoyama K; Oshima M; Koide S; Suzuki E; Mochizuki-Kashio M; Kato Y; Tara S; Shinoda D; Hiura N; Nakajima-Takagi Y; Sashida G; Iwama A
iScience; 2018 Nov; 9():161-174. PubMed ID: 30396150
[TBL] [Abstract][Full Text] [Related]
28. Divergent Requirements for EZH1 in Heart Development Versus Regeneration.
Ai S; Yu X; Li Y; Peng Y; Li C; Yue Y; Tao G; Li C; Pu WT; He A
Circ Res; 2017 Jul; 121(2):106-112. PubMed ID: 28512107
[TBL] [Abstract][Full Text] [Related]
29. Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors.
Lanzi C; Arrighetti N; Pasquali S; Cassinelli G
Biochem Pharmacol; 2023 Sep; 215():115727. PubMed ID: 37541451
[TBL] [Abstract][Full Text] [Related]
30. Exercise-induced histone H3 trimethylation at lysine 27 facilitates the adaptation of skeletal muscle to exercise in mice.
Shimizu J; Kawano F
J Physiol; 2022 Jul; 600(14):3331-3353. PubMed ID: 35666835
[TBL] [Abstract][Full Text] [Related]
31. EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.
Johnstone AL; O'Reilly JJ; Patel AJ; Guo Z; Andrade NS; Magistri M; Nathanson L; Esanov R; Miller BH; Turecki G; Brothers SP; Zeier Z; Wahlestedt C
Neurobiol Dis; 2018 Nov; 119():149-158. PubMed ID: 30099093
[TBL] [Abstract][Full Text] [Related]
32. Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57
Li W; Bi C; Han Y; Tian T; Wang X; Bao H; Xu X; Zhang X; Liu L; Zhang W; Gao H; Wang H; Zhang H; Meng B; Wang X; Fu K
Cancer Biol Med; 2019 Aug; 16(3):530-541. PubMed ID: 31565482
[TBL] [Abstract][Full Text] [Related]
33. Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells
Al-Ghabkari A; Narendran A
Cancer Biol Ther; 2021 Apr; 22(4):333-344. PubMed ID: 33978549
[TBL] [Abstract][Full Text] [Related]
34. Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner.
Mochizuki-Kashio M; Aoyama K; Sashida G; Oshima M; Tomioka T; Muto T; Wang C; Iwama A
Blood; 2015 Sep; 126(10):1172-83. PubMed ID: 26219303
[TBL] [Abstract][Full Text] [Related]
35. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Retinal Development via the Epigenetic Modification of Histone H3.
Watanabe S; Murakami A
Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469
[TBL] [Abstract][Full Text] [Related]
37. Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth.
Garapaty-Rao S; Nasveschuk C; Gagnon A; Chan EY; Sandy P; Busby J; Balasubramanian S; Campbell R; Zhao F; Bergeron L; Audia JE; Albrecht BK; Harmange JC; Cummings R; Trojer P
Chem Biol; 2013 Nov; 20(11):1329-39. PubMed ID: 24183969
[TBL] [Abstract][Full Text] [Related]
38. Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development.
Völkel P; Bary A; Raby L; Chapart A; Dupret B; Le Bourhis X; Angrand PO
Sci Rep; 2019 Mar; 9(1):4319. PubMed ID: 30867490
[TBL] [Abstract][Full Text] [Related]
39. Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.
Fujita S; Honma D; Adachi N; Araki K; Takamatsu E; Katsumoto T; Yamagata K; Akashi K; Aoyama K; Iwama A; Kitabayashi I
Leukemia; 2018 Apr; 32(4):855-864. PubMed ID: 28951561
[TBL] [Abstract][Full Text] [Related]
40. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
